Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Recipharm prices IPO at SEK 78 per share


Thursday, 3 Apr 2014 01:30am EDT 

Recipharm publ AB:Prices Initial Public Offering (IPO) at 78 Swedish crowns per share of series B.Receives about 815 million crowns in gross proceeds.Says the price corresponds to a market value of all shares issued by Recipharm of 2,794 million crowns.To cover potential over-allotment Lars Backsell and Thomas Eldered have undertaken to sell additional existing shares corresponding to up to 15 percent of the number of shares of series B comprised by the IPO, not more than 2,517,884 shares of series B.Says the total value of IPO is 1,506 million crowns, assuming the over-allotment option is exercised in full.Says trading in Recipharm shares of series B on NASDAQ OMX Stockholm commences on April 3.